The Narcotics Control Bureau (NCB) has dismantled a major inter-state drug trafficking network stretching from the national capital Delhi all the way to Kashmir. In a joint operation conducted by the Jammu and Delhi units of the agency, four individuals involved in supplying narcotics have been apprehended. Authorities recovered massive quantities of restricted pharmaceutical drugs and cough syrup that were being illegally diverted into the valley.
Initial bust aboard a passenger bus in Udhampur
The breakthrough in the case began on November 16, when the NCB Jammu unit intercepted a Srinagar-bound passenger bus near the Mada toll plaza in Chenani, Udhampur district. Approximately 7 kilograms of codeine-based cough syrup were recovered from the possession of a passenger hailing from Bhadarwah in Doda district. Following this lead, further investigation in the Kashmir valley led authorities to capture the main receiver based in Anantnag.
Illegal warehouse operating from a rented house in Delhi
As the investigation trail extended to Delhi, enforcement teams uncovered a clandestine drug warehouse operating inside a rented residential premise. Continuous raids at the location led to the seizure of over five lakh prescription tablets, capsules, and bottles. The recovered pharmaceutical stockpile included controlled substances such as Tramadol, Alprazolam, Nitrazepam, and codeine-based products.
Arrests and subsequent recoveries
Following the arrest of operatives linked to the distribution network in Delhi, an additional 356 bottles of codeine cough syrup were recovered on November 18. This breakthrough pointed authorities toward the illegal storage facility operating in a rented building in Shahdra, Delhi. During raids conducted on November 18 and 19, officials seized upwards of five lakh pills, capsules, and bottles. A total of four accused persons have been arrested in connection with the syndicate so far.
Tracing the supply chain and financial trail
The NCB is currently investigating how the codeine-based cough syrup and other pharmaceutical drugs were illicitly diverted from legitimate supply chains. Investigators are probing the primary sources of procurement, major suppliers, local distributors, and financial transactions tied to the network to dismantle the entire operation from root to branch.



















